HDAC4/MybL1/YAP novel signaling axis is required for pancreatic cancer metastasis to the liver

By afschroeder • November 25, 2025

Edderkaoui M, Elmadbouh OHM, Lim A, Ou Y, Hauptschein D, Guha A, Darwish A, Calsavara VF, Murali R, Bhowmick N, Osipov A, Mathison AJ, Urrutia R, Wang Q, Pandol SJ. HDAC4/MybL1/YAP novel signaling axis is required for pancreatic cancer metastasis to the liver. Int J Biol Sci. 2025 Oct 24;21(15):6907-6925. doi: 10.7150/ijbs.102132. PMID: 41281751; PMCID: PMC12631223.

Tags: Cedars Sinai DoM, Digestive Diseases, Hematology/Oncology, Publications

Temporal trends in the clinical utilization of cardiac imaging tests: 2008-2024

Rozanski A, Gransar H, Miller R, Slomka P, Han D, Hayes S, Friedman J, Berman D. Temporal trends in the clinical utilization of cardiac imaging[...]

Improved Assessment of Coronary Artery Disease in Obese Subjects with Flurpiridaz-18F PET Myocardial Perfusion Imaging: A Prespecified Subgroup Analysis of the AURORA Phase 3 Study

Patel KK, Maddahi J, Agostini D, Bax JJ, Beanlands RSB, Berman D, Dorbala S, Heller GV, Knuuti JM, Pelletier-Galarneau M, Tamaki N, Thompson D, Somer[...]

30-Day Outcomes of a Single-Stage Transfemoral Mitral Valve Replacement System in Severe Mitral Valve Disease

Yadav PK, Vahl TP, Thourani VH, Latib A, Chehab BM, Rinaldi M, Makkar R, Rogers JH, Rodés-Cabau J, Singh G, Gössl M, Sorajja P, Reardon[...]